Video

Kyu Rhee: Using Watson's Technology in Oncology and Endocrinology

Author(s):

At the recent ASCO conference in Chicago it was announced that Watson Health would be used to help with cancer treatment. A similar announcement was made at the American Diabetes Association's annual meeting in New Orleans.

At the recent ASCO conference in Chicago, it was announced that IBM Watson Health would be used to help with cancer treatment. A similar announcement was made at the American Diabetes Association's annual meeting in New Orleans.

Speaking at the Louisiana meeting Kyu Rhee, MD, MPP, chief health officer for IBM Watson Health, discussed how the programs would be similar but also how the unique challenges associated with the treatment of diabetes would be addressed in this collaboration as well.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
© 2025 MJH Life Sciences

All rights reserved.